MedTrace Logo

Study of Key Electro-acupuncture Technique on Migraine

NCT02580968 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2020-02-05

No results posted yet for this study

Summary

A random controlled trail to evaluate the efficacy of migraine standard electroacupuncture formula, and to analysis the regulation of the intensity-effects and to observe the peripheral NO, CGRP and NF-кB expression level of migraine patients after electroacupuncture treatment.

Conditions

Interventions

DEVICE

electro-acupuncture

electro-acupuncture on acupoints according to the traditional syndrome diagnosis.once per day, for 20 days.

DRUG

flunarizine hydrochloride

flunarizine hydrochloride ，10mg/day，for 20 days。

Sponsors & Collaborators

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Jian Pei, Ph.D · Longhua Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580968 on ClinicalTrials.gov